Supplemental material for The effectiveness and safety of biological therapeutics in juvenile-onset systemic lupus erythematosus (JSLE): a systematic review by E Peterknecht, M P Keasey and M W Beresford in Lupus</p
Supplemental material, Supplemental Material5 for The impact of SLE on health-related quality of lif...
The development of biological therapies has had an impact on the management of several medical condi...
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease. It is characterized by a variab...
Objective: To systematically review and summarize the available literature regarding the effectivene...
Supplemental material, Supplemental Material3 for Infectious complications in lupus nephritis treatm...
Supplemental material, Supplemental Material2 for Infectious complications in lupus nephritis treatm...
IntroductionJuvenile-onset systemic lupus erythematous (JSLE) is a rare multisystem autoimmune disor...
Supplemental Material for Risk of livedo with antiphospholipid antibodies in patients with systemic ...
Supplemental material, Supplemental Material3 for The impact of SLE on health-related quality of lif...
Supplemental Material for Real-world use and outcomes of belimumab in childhood-onset lupus: A singl...
<p>Supplemental material for A 6-month open-label extension study of the safety and efficacy of subc...
Supplemental material, Supplemental Material2 for The impact of SLE on health-related quality of lif...
Supplemental material, Supplemental Material1 for The impact of SLE on health-related quality of lif...
Supplemental material, Supplemental Material4 for The impact of SLE on health-related quality of lif...
Supplemental Material for Refractory lupus nephritis: a survey by M Weidenbusch, Y Bai, J Eder and H...
Supplemental material, Supplemental Material5 for The impact of SLE on health-related quality of lif...
The development of biological therapies has had an impact on the management of several medical condi...
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease. It is characterized by a variab...
Objective: To systematically review and summarize the available literature regarding the effectivene...
Supplemental material, Supplemental Material3 for Infectious complications in lupus nephritis treatm...
Supplemental material, Supplemental Material2 for Infectious complications in lupus nephritis treatm...
IntroductionJuvenile-onset systemic lupus erythematous (JSLE) is a rare multisystem autoimmune disor...
Supplemental Material for Risk of livedo with antiphospholipid antibodies in patients with systemic ...
Supplemental material, Supplemental Material3 for The impact of SLE on health-related quality of lif...
Supplemental Material for Real-world use and outcomes of belimumab in childhood-onset lupus: A singl...
<p>Supplemental material for A 6-month open-label extension study of the safety and efficacy of subc...
Supplemental material, Supplemental Material2 for The impact of SLE on health-related quality of lif...
Supplemental material, Supplemental Material1 for The impact of SLE on health-related quality of lif...
Supplemental material, Supplemental Material4 for The impact of SLE on health-related quality of lif...
Supplemental Material for Refractory lupus nephritis: a survey by M Weidenbusch, Y Bai, J Eder and H...
Supplemental material, Supplemental Material5 for The impact of SLE on health-related quality of lif...
The development of biological therapies has had an impact on the management of several medical condi...
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease. It is characterized by a variab...
DOI
Add to ORKG